When researchers measure the activity of thousands of genes at once, they face a paradox that has shaped computational biology for decades: far too many variables and far too few samples. A single DNA ...
Doctors initially told the boy's parents not to worry. But they pressed for years until a rare diagnosis became clear.
A rice lineage derived from seeds treated with 100 megapascals of hydrostatic pressure still shows reduced height, tiller ...
Unlock ROI with segment and regional insights, competitive intelligence, growth opportunities, innovation trends, and actionable strategies for new revenue streams.Dublin, Oct. 05, 2026 (GLOBE ...
GeneDx, the leader in rare disease diagnosis and improving health through the power of genomic data, today announced it will ...
Figure 1. The 18A queue by month of latest Application Proof, coloured by the modality of each applicant's lead asset. Solid ...
LONDON, ON and HERZLIYA, ISRAEL, Oct. 5, 2026 /CNW/ -- EpiSign Inc. and Geneyx Genomex Ltd. today announced a partnership to advance the integration of genomic and epigenomic analysis for rare-disease ...
Pacific Biosciences of California's business model struggles to gain traction versus larger, profitable competitors like Illumina. Read why PACB stock is a buy.
A prespecified analysis of a phase 3 trial evaluated the ability of PAM50 molecular prostate cancer subtypes to predict benefit from salvage treatment intensification.
VitroVivo Biotech LLC, a Maryland-based provider of histology and molecular histopathology products and laboratory services, is expanding access to specialized tissue-based research support through ...
Atomica, a U.S.-based microfabrication foundry, today announced the launch of its Biotechnology Microdevices Platform, the seventh in ...
Vaccines.When you hear that, what comes to mind?Rolling up your sleeve and getting it disinfected.The doctor brings out a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results